The British Menopause Society is the specialist authority for menopause and post reproductive health in the UK. Established in 1989, the BMS educates, informs and guides healthcare professionals, working in both primary and secondary care, on menopause and all aspects of post reproductive health.
Media enquiries
Members of our board of trustees and medical advisory council are leading specialists in menopause and post-reproductive healthcare and are happy to provide clinical comment.
MEDICAL/HEALTH PRESS
If you are planning a health article or piece for healthcare professionals and looking for a specialist comment, please get in touch with us via our contact form:
Below are other menopause resources you may find helpful.
CONSUMER PRESS
If your article/enquiry is for a consumer audience, please use our consumer media contact form on the Women’s Health Concern website.
Women’s Health Concern is our patient arm and on that website you can find up-to-date information, leaflets and factsheets for a consumer audience on a number of conditions such as the menopause, endometriosis, PMS, cervical and ovarian cancer and many more, which can be downloaded from our WHC factsheets and other helpful resources page.
Current issues, hot media topics and press statements
Early and premature menopause associated with increased cardiovascular risk, major global study confirms
A large multinational cohort study published in Lancet Obstetrics, Gynaecology & Women’s Health (Marschner et al., 2026) followed 111,619 women across 26 countries over a median of 14.6 years.
Premature and early menopause were consistently associated with a greater risk of major cardiovascular events, including myocardial infarction, fatal cardiovascular disease, and stroke, across all regions and ethnic groups studied.
Mr Haitham Hamoda, British Menopause Society, said women with premature and early menopause had approximately a 30% greater risk of major cardiovascular events after adjusting for risk factors. Professor Janice Rymer, BMS Chair, said the findings confirm the need to identify these women and proactively manage modifiable cardiovascular risk factors.
Read the full study: Early menopause and its association with cardiovascular outcomes (PURE): a multinational prospective cohort study
New BMS Tool for Clinicians: Menopausal ‘brain fog’ or dementia?
Cognitive symptoms such as memory lapses and difficulty concentrating are frequently reported during perimenopause and menopause, and can prompt concern about dementia.
This new BMS Tool provides evidence-based guidance to help clinicians differentiate menopausal cognitive symptoms from early neurodegenerative disease, and highlights that sleep, stress, and other health conditions may also contribute.
Menopausal ‘brain fog’ or dementia? – a practical guide for clinicians
Updated dose tables for estrogen and progestogen prescribing in BMS and WHC resources
Based on a BMS consensus review of current evidence, the following resources have been updated to ensure consistency in the tables detailing approximate equivalent estrogen doses and the suggested progestogen doses per licensed estrogen dose when prescribing progestogen and estrogen separately:
BMS joint guideline on the management of unscheduled bleeding on HRT
BMS Tool for Clinicians: HRT – Practical prescribing
WHC Fact Sheet: HRT – types, doses and regimens
WHC Fact Sheet: Management of unscheduled bleeding on HRT
Read the BMS news alert: Updated dose tables for estrogen and progestogen prescribing in BMS and WHC resources
Further information: BMS Tool for Clinicians on Progestogens and endometrial protection
Misinformation about perimenopause on social media ‘putting women at risk’
A recent article in The Guardian, featuring Dr Paula Briggs, BMS trustee, highlighted concerns that misinformation about perimenopause on social media may be putting women at risk of unintended pregnancies, unnecessary medication, and missed diagnoses.
This issue was also addressed during a lecture by Dr James Larkin on misinformation online at the BMS 35th Annual Scientific Conference. The Society continues to encourage healthcare professionals to remain alert to the impact of misinformation on patient understanding and behaviour.
Read The Guardian article: Misinformation about perimenopause on social media ‘putting women at risk’
Useful menopause resources
Key documents
Latest news
BMS announces new Director of Clinical Practice
The board of trustees of the British Menopause Society (BMS) is pleased to announce the appointment of Kathy Abernethy as Director of Clinical Practice, a new role within the Society. Kathy Abernethy is a [...]
International Menopause Society survey: ovarian ageing, menopause, premature ovarian insufficiency and genetics
Premature ovarian insufficiency (POI) and early menopause (EM) affect an estimated 4% and 12% of women respectively, with significant adverse health and psychological impacts. In 2024, the International Menopause Society (IMS), in partnership with [...]
Have your say on VVA: a new survey for healthcare professionals
Healthcare professionals who see menopausal women with vulvo-vaginal atrophy (VVA), as part of genitourinary syndrome of menopause (GSM), are invited to take part in a new University of Melbourne survey exploring how this condition [...]
MHRA has added to the license for Elinzanetant
Extended MHRA licence for elinzanetant in breast cancer patients The Medicines and Healthcare products Regulatory Agency (MHRA) has extended the licence for elinzanetant, an NK1/NK3 receptor antagonist, for the treatment of moderate to severe [...]
New WHC Fact Sheet: Hormone blood tests in the menopause transition
New WHC Fact Sheet: Hormone blood tests in the menopause transition Women's Health Concern (WHC), the patient arm of the British Menopause Society (BMS), has published a new fact sheet examining the role of [...]
Press announcements
Search
Enter key words here to search all BMS press announcements: